JENNIFER BILKER: Open Payments
NPI 1760236814 · BEL AIR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,449 in 52 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $813 · 2025 $1,449
Food & beverage: $1,449
| Company | Payments | Amount |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 4 | $385 |
| Novo Nordisk Inc | 11 | $284 |
| E.R. Squibb & Sons, L.L.C. | 10 | $175 |
| Lilly USA, LLC | 4 | $100 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $81 |
| Merck Sharp & Dohme LLC | 3 | $73 |
| PFIZER INC. | 3 | $58 |
| Esperion Therapeutics, Inc. | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $33 |
Products named: Assure WCD, Wegovy, ELIQUIS, CAMZYOS, JARDIANCE, VERQUVO, ZEPBOUND, MOUNJARO.
Industry payments across MD — which companies pay providers there.
